Pharmacokinetics and antihypertensive effects of lisinopril in hypertensive patients with normal and impaired renal function.

Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.

Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function.

Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Pharmacokinetics of cefazolin patients with normal and impaired renal function.

Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.

Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.

Lisinopril in hypertensive patients with renal function impairment.

Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.

Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.

Pharmacokinetics of cefamandole in patients with normal and impaired renal function.

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Pharmacokinetics of nicorandil in patients with normal and impaired renal function.

[Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].

Pharmacokinetics of pancuronium in patients with normal and impaired renal function.

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

Carbenicillin therapy in patients with normal and impaired renal function.

Pharmacokinetics of carteolol in patients with impaired renal function.

Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.

Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function.

Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function.

Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.

Pharmacokinetics of nomifensine in impaired renal function.

Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Suggest Documents

Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.

Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function.

Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function.

Pharmacokinetics of cefazolin patients with normal and impaired renal function.

Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.

Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.

Lisinopril in hypertensive patients with renal function impairment.

Mezlocillin pharmacokinetics in patients with normal and impaired renal functions.

Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.

Pharmacokinetics of cefamandole in patients with normal and impaired renal function.

Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Pharmacokinetics of nicorandil in patients with normal and impaired renal function.

[Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].

Pharmacokinetics of pancuronium in patients with normal and impaired renal function.

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.

Carbenicillin therapy in patients with normal and impaired renal function.

Pharmacokinetics of carteolol in patients with impaired renal function.

Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.

Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function.

Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function.

Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.

Pharmacokinetics of nomifensine in impaired renal function.

Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Pharmacokinetics and antihypertensive effects of lisinopril in hypertensive patients with normal and impaired renal function.

Recommend Documents

Follow Us